XML 44 R30.htm IDEA: XBRL DOCUMENT v3.20.4
4. Intangible Assets, Goodwill and Other (Tables)
12 Months Ended
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes to goodwill by segment
Changes to goodwill by segment were as follows (in millions):
 20202019
Life
Science
Clinical
Diagnostics
TotalLife
Science
Clinical
Diagnostics
Total
Balances as of January 1:      
Goodwill$250.1 $349.2 $599.3 $234.5 $320.5 $555.0 
Accumulated impairment losses and write-offs(41.8)(293.4)(335.2)(41.8)(293.4)(335.2)
Goodwill, net208.3 55.8 264.1 192.7 27.1 219.8 
Acquisitions (see Note 2)29.8 — 29.8 15.6 28.7 44.3 
Other adjustments (see Note 2)(2.0)— (2.0)— — — 
Period increase, net27.8 — 27.8 15.6 28.7 44.3 
Balances as of December 31:      
Goodwill277.9 349.2 627.1 250.1 349.2 599.3 
Accumulated impairment losses and write-offs(41.8)(293.4)(335.2)(41.8)(293.4)(335.2)
Goodwill, net$236.1 $55.8 $291.9 $208.3 $55.8 $264.1 
Schedule of Finite-Lived Intangible Assets by Major-Class
Information regarding our identifiable purchased intangible assets with definite and indefinite lives is as follows (in millions):
December 31, 2020
Weighted-Average Amortization Period (years)Purchase
Price
Accumulated
Amortization
Net
Carrying
Amount
Customer relationships/lists5.51$116.6 $(87.2)$29.4 
Know how4.75196.6 (175.4)21.2 
Developed product technology14.00218.1 (107.1)111.0 
Licenses7.7365.6 (37.4)28.2 
Tradenames7.826.6 (4.2)2.4 
Covenants not to compete3.874.5 (2.0)2.5 
Other0.1 (0.1)— 
     Total definite-lived intangible assets608.1 (413.4)194.7 
In-process research and development4.8 — 4.8 
     Total purchased intangible assets$612.9 $(413.4)$199.5 
 December 31, 2019
Weighted-Average Amortization Period (years)Purchase
Price
Accumulated
Amortization
Net
Carrying
Amount
Customer relationships/lists6.36$107.2 $(74.3)$32.9 
Know how5.71188.5 (162.6)25.9 
Developed product technology8.31144.2 (93.9)50.3 
Licenses8.7476.0 (44.4)31.6 
Tradenames8.506.4 (3.6)2.8 
Covenants not to compete6.013.2 (1.4)1.8 
Other0.1 (0.1)— 
Total definite-lived intangible assets 525.6 (380.3)145.3 
In-process research and development0.2 — 0.2 
Total purchased intangible assets$525.8 $(380.3)$145.5